Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04080128 · ClinicalTrials.gov registry record
Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 248
- Enrollment target
NCT04080128: Completed study, sponsored by Ohio State University.
NCT04080128 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 248 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04080128 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 248 participants
- Enrollment target
Study Summary
This project intends to provide important, previously unmet answers regarding biological associations with myopia (nearsightedness) progression in order to improve the ability to predict patients who are most likely to benefit from myopia control, as well as questions frequently posed by patients and practitioners about the side effects, mechanism, and discontinuation of soft bifocal contact lens myopia control. The first three aims examine the association between biological variables that can be measured non-invasively and myopia progression, and they will be conducted regardless of the outcome of the currently in progress BLINK Study. The last three specific aims will be conducted if soft bifocal contact lenses slowed myopia progression by 30% or more in the BLINK Study, and they can be investigated with very few additional measurements.
Primary Outcome
test the hypothesis that thinner subfoveal choroidal thickness (a layer of blood vessels) is associated with the outcome of greater axial elongation (eye growth) The hypothesis relates to the two years of multifocal contact lens wear and one year of single vision contact lens wear. As such, it uses the entire sample which experiences the same contact lens wear in the BLINK2 Study.
Interventions
- DEVICE Contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2024-01-04 |
What the finished NCT04080128 record still lists
NCT04080128 is an observational study that tracks outcomes without assigning an intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Contact lenses is the first listed.
NCT04080128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04080128 about?
NCT04080128 is a clinical study titled "Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control". This project intends to provide important, previously unmet answers regarding biological associations with myopia (nearsightedness) progression in order to improve the ability to predict patients who are most likely to benefit from myopia control, as well as questions frequently posed by patients an...
What is the current status of trial NCT04080128?
This trial is currently completed. The enrollment target is 248 participants. The study started on 2019-09-09. Estimated completion is 2024-01-04.
What interventions are being tested in trial NCT04080128?
The interventions under investigation include: Contact lenses (DEVICE).
Who is sponsoring clinical trial NCT04080128?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI